Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling

Kimberly R. Kalli, Oluwole I. Falowo, Laurie K. Bale, Michael A. Zschunke, Patrick C. Roche, Cheryl A Conover

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

The insulin receptor mediates a proliferative response in certain transformed cells, but little is known about its function in ovarian cancer. We used human epithelial ovarian carcinoma cell lines and lifespan-extended normal ovarian surface epithelial (OSE) cells to examine 125I-insulin binding and mitogenic responses to insulin. All cancer cell and OSE cultures specifically bound 125I-insulin. Except for OV202, the carcinoma lines had elevated insulin binding compared with OSE cells. All carcinoma lines except OV202 expressed insulin receptor as detected by flow cytometry and increased 3Hthymidine incorporation or cell number in response to 0.1-10 nM insulin. Interestingly, similar concentrations of IGF-II also induced proliferation of the insulin-responsive cancer cell lines and displaced 125I-insulin binding. Direct binding of 125I-IGF-II to the insulin receptor was visualized by cross-linking and immunoprecipitation. Binding of IGF-II to the insulin receptor and a proliferative effect of insulin suggest the presence of insulin receptor isoform A. Real-time PCR analyses confirm that insulin receptor isoform A expression predominates over isoform B expression in the ovarian carcinoma cell lines. This report suggests that the insulin receptor may play a role in the regulation of ovarian cancer cell growth.

Original languageEnglish (US)
Pages (from-to)3259-3267
Number of pages9
JournalEndocrinology
Volume143
Issue number9
DOIs
StatePublished - Sep 2002

Fingerprint

Insulin-Like Growth Factor II
Insulin Receptor
Insulin
Carcinoma
Ovarian Neoplasms
Protein Isoforms
Cell Line
Epithelial Cells
human INSR protein
Immunoprecipitation
Real-Time Polymerase Chain Reaction
Flow Cytometry
Cell Count
Growth

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Functional insulin receptors on human epithelial ovarian carcinoma cells : Implications for IGF-II mitogenic signaling. / Kalli, Kimberly R.; Falowo, Oluwole I.; Bale, Laurie K.; Zschunke, Michael A.; Roche, Patrick C.; Conover, Cheryl A.

In: Endocrinology, Vol. 143, No. 9, 09.2002, p. 3259-3267.

Research output: Contribution to journalArticle

Kalli, Kimberly R. ; Falowo, Oluwole I. ; Bale, Laurie K. ; Zschunke, Michael A. ; Roche, Patrick C. ; Conover, Cheryl A. / Functional insulin receptors on human epithelial ovarian carcinoma cells : Implications for IGF-II mitogenic signaling. In: Endocrinology. 2002 ; Vol. 143, No. 9. pp. 3259-3267.
@article{8b12d7e17b6a4f33945d09206fe51bac,
title = "Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling",
abstract = "The insulin receptor mediates a proliferative response in certain transformed cells, but little is known about its function in ovarian cancer. We used human epithelial ovarian carcinoma cell lines and lifespan-extended normal ovarian surface epithelial (OSE) cells to examine 125I-insulin binding and mitogenic responses to insulin. All cancer cell and OSE cultures specifically bound 125I-insulin. Except for OV202, the carcinoma lines had elevated insulin binding compared with OSE cells. All carcinoma lines except OV202 expressed insulin receptor as detected by flow cytometry and increased 3Hthymidine incorporation or cell number in response to 0.1-10 nM insulin. Interestingly, similar concentrations of IGF-II also induced proliferation of the insulin-responsive cancer cell lines and displaced 125I-insulin binding. Direct binding of 125I-IGF-II to the insulin receptor was visualized by cross-linking and immunoprecipitation. Binding of IGF-II to the insulin receptor and a proliferative effect of insulin suggest the presence of insulin receptor isoform A. Real-time PCR analyses confirm that insulin receptor isoform A expression predominates over isoform B expression in the ovarian carcinoma cell lines. This report suggests that the insulin receptor may play a role in the regulation of ovarian cancer cell growth.",
author = "Kalli, {Kimberly R.} and Falowo, {Oluwole I.} and Bale, {Laurie K.} and Zschunke, {Michael A.} and Roche, {Patrick C.} and Conover, {Cheryl A}",
year = "2002",
month = "9",
doi = "10.1210/en.2001-211408",
language = "English (US)",
volume = "143",
pages = "3259--3267",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Functional insulin receptors on human epithelial ovarian carcinoma cells

T2 - Implications for IGF-II mitogenic signaling

AU - Kalli, Kimberly R.

AU - Falowo, Oluwole I.

AU - Bale, Laurie K.

AU - Zschunke, Michael A.

AU - Roche, Patrick C.

AU - Conover, Cheryl A

PY - 2002/9

Y1 - 2002/9

N2 - The insulin receptor mediates a proliferative response in certain transformed cells, but little is known about its function in ovarian cancer. We used human epithelial ovarian carcinoma cell lines and lifespan-extended normal ovarian surface epithelial (OSE) cells to examine 125I-insulin binding and mitogenic responses to insulin. All cancer cell and OSE cultures specifically bound 125I-insulin. Except for OV202, the carcinoma lines had elevated insulin binding compared with OSE cells. All carcinoma lines except OV202 expressed insulin receptor as detected by flow cytometry and increased 3Hthymidine incorporation or cell number in response to 0.1-10 nM insulin. Interestingly, similar concentrations of IGF-II also induced proliferation of the insulin-responsive cancer cell lines and displaced 125I-insulin binding. Direct binding of 125I-IGF-II to the insulin receptor was visualized by cross-linking and immunoprecipitation. Binding of IGF-II to the insulin receptor and a proliferative effect of insulin suggest the presence of insulin receptor isoform A. Real-time PCR analyses confirm that insulin receptor isoform A expression predominates over isoform B expression in the ovarian carcinoma cell lines. This report suggests that the insulin receptor may play a role in the regulation of ovarian cancer cell growth.

AB - The insulin receptor mediates a proliferative response in certain transformed cells, but little is known about its function in ovarian cancer. We used human epithelial ovarian carcinoma cell lines and lifespan-extended normal ovarian surface epithelial (OSE) cells to examine 125I-insulin binding and mitogenic responses to insulin. All cancer cell and OSE cultures specifically bound 125I-insulin. Except for OV202, the carcinoma lines had elevated insulin binding compared with OSE cells. All carcinoma lines except OV202 expressed insulin receptor as detected by flow cytometry and increased 3Hthymidine incorporation or cell number in response to 0.1-10 nM insulin. Interestingly, similar concentrations of IGF-II also induced proliferation of the insulin-responsive cancer cell lines and displaced 125I-insulin binding. Direct binding of 125I-IGF-II to the insulin receptor was visualized by cross-linking and immunoprecipitation. Binding of IGF-II to the insulin receptor and a proliferative effect of insulin suggest the presence of insulin receptor isoform A. Real-time PCR analyses confirm that insulin receptor isoform A expression predominates over isoform B expression in the ovarian carcinoma cell lines. This report suggests that the insulin receptor may play a role in the regulation of ovarian cancer cell growth.

UR - http://www.scopus.com/inward/record.url?scp=0036721496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036721496&partnerID=8YFLogxK

U2 - 10.1210/en.2001-211408

DO - 10.1210/en.2001-211408

M3 - Article

C2 - 12193537

AN - SCOPUS:0036721496

VL - 143

SP - 3259

EP - 3267

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -